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Abstract
Background: Postoperative pain is a major complaint following abdominal surgery for gynecological diseases. Effective
postoperative pain control after abdominal surgery is particularly important for patient recovery, mobility, and satisfaction.
Acupuncture has been commonly used for pain management. However, its efficacy in postoperative pain control is
inconclusive and health economic evaluation is limited.
Methods: A randomized, sham-controlled, patient- and- assessor-blind trial is designed to evaluate the efficacy and safety
of acupuncture in managing postoperative pain following abdominal surgery of gynecological diseases. Patients who are
eligible for laparotomy with a midline incision for gynecological neoplasia, including ovarian mass, uterine mass, and
cervical lesions, will be recruited. Seventy-two participants will be randomly allocated to an acupuncture or non-invasive
sham control in a 1:1 ratio. Treatment will be done within 2 h before operation, upon arrival to the ward and once daily
for 5 days. The Pain Numerical Rating Scale (NRS) on the first 5 days during hospitalization will be the primary outcome
and will be analyzed using the area-under-the-curve (AUC) method. The secondary outcome measures include frequency
of rescue analgesic use during hospital stay, cumulative morphine consumption; quality of recovery as measured by time
to recovery variables and the Quality of Recovery-9 (QoR-9); quality of life as measured by the Short Form-6 dimension
(SF-6D) and EuroQol-5 Dimension-5 Level (EQ-5D-5 L). The incremental cost-effectiveness ratio of acupuncture vs sham
acupuncture will be calculated.
Discussion: This study protocol provides an example of integrative medicine practice in a hospital setting for the
management of postoperative pain using acupuncture treatment. The acupuncture treatment protocol, if proven to be
effective, can be implemented in routine settings to play a role in postoperative pain management for patients who
have undergone abdominal surgery for gynecological diseases.
Trial registration: ClinicalTrials.gov, ID: NCT02851186. Registered on 19 July 2016.
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Background
Postoperative pain is a major complaint following
abdominal surgery for gynecological diseases. Effective
postoperative pain control after abdominal surgery is
particularly important for patient recovery, mobility, and
satisfaction. Pain at the intra-abdominal incision site
may interfere with deep breathing which is necessary for
early ambulation. If the acute pain is inadequately
treated, it may become chronic; surgery contributes to
chronic pain in 23% of patients in outpatient pain clinics
[1]. Pharmacological agents, such as epidural anesthesia,
intraspinal anesthesia, intrapleural anesthesia, or patient-
controlled analgesia (PCA), are effective in relieving
postoperative pain in most patients. However, analgesic
drugs, especially opioid analgesics, are associated with
complications including drowsiness, pruritus, nausea
and vomiting and respiratory depression. Thus, a safe
and effective treatment for postoperative pain is needed.
Acupuncture is defined as needling at acupoints on
the human body surface, including the trunk, limbs,
scalp, and auricle. Acupuncture has been commonly
used for pain management in the Asian population. Its
analgesic effect has been well documented. Emerging
evidence shows that acupuncture’s analgesic effects
involves a variety of bioactive chemicals through periph-
eral, spinal and supraspinal mechanisms [2]. Acupunc-
ture can induce endogenous opioids which desensitize
peripheral nociceptors and reduce proinflammatory
cytokines in peripheral tissues and the spinal cord.
Acupuncture also suppresses N-methyl-d-aspartate
receptors (NMDAR) by inducing endogenous opioids in
the intrarostral anterior cingulate cortex of the brain,
which contributes to the inhibition of the affective
dimension of pain [2].
Several studies have shown that acupuncture can
relieve pain after gynecological surgeries [3–5], abdom-
inal surgeries [6–8], and other types of surgeries includ-
ing oral surgery [9], thoracotomy [10], cardiac surgery
[11], and laparoscopic cholecystectomy [12–14]. There
have been six systematic reviews of acupuncture or com-
plementary therapies for postoperative pain. Four of the
six reviews [15–18] suggested that acupuncture is poten-
tially useful in the management of postoperative pain. In
the review of acupuncture on postoperative pain after
back surgery conducted by Cho et al. [15], a pooled
meta-analysis of five high-quality trials showed that acu-
puncture reduced Visual Analog Scale (VAS) pain scores
(standard mean difference (SMD) = 0.67 (95% confidence
interval (CI) 1.04 to 0.31)), but not opioid consumption
(SMD = − 0.23 (95% CI − 0.58 to 0.13)), when compared
to sham control at 24 h following back surgery. In a
meta-analysis by Sun et al. [16], the acupuncture group
showed a significantly lower cumulative opioid analgesic
consumption at 8, 24, and 72 h (weighted mean
difference (WMD) = – 3.14 mg (95% CI − 5.15 to − 1.14),
− 8.33 mg (95% CI − 11.06 to − 5.61), and − 9.14 mg (95%
CI − 16.07 to − 2.22), respectively) and pain level at 8
and 72 h (WMD = – 14.57 mm (95% CI − 23.02 to −
6.13) and − 9.75 mm (95% CI − 13.82 to − 5.68), respect-
ively) in comparison to sham control after a wide range
of operations, including abdominal surgery. Asher et al.
[17] performed a review on auriculotherapy, suggesting
that auriculotherapy is an effective intervention in reliev-
ing perioperative pain as suggested by the reduced
analgesic use (SMD 0.54 (95% CI 0.30 to 0.77)). Another
systematic review on auricular acupuncture by Usi-
chenko et al. [18] found that the evidence of auricular
acupuncture in reducing postoperative pain is promising
(eight out of nine included studies supported the use of
auricular acupuncture when compared to control, but
no meta-analysis was done due to the heterogeneity of
the studies) but not compelling due to poor methodo-
logical quality of studies. Although the use of acupunc-
ture in postoperative pain control was not supported
either review [19, 20], these reviews focused on pain
management after ambulatory knee surgery [19] and
orthopedic surgery [20] which may be quite different
from abdominal surgery.
Electroacupuncture (EA) at PC6, ST36 bilaterally, and
along the skin incision subcutaneously is better than
sham EA in relieving postoperative abdominal pain as
measured by postoperative morphine consumption in 6–
12 h after operation in the study by Sim [3]. Zeng et al.
(2014), found that the analgesic effect as measured by
total pain remission rates calculated from VAS at 2, 4,
and 6 h after treatment in the acupuncture group were
better than those in the orally administered morphine
sulphate group (63.3% vs 50%; 73.3% vs 66.7%, and 100%
vs 76.7%, respectively) [8]. Auricular acupuncture (AA),
a variant of acupuncture, is also widely used for the
management of pain by Chinese medicine practitioners.
A previous systematic review concluded that the
evidence on AA reducing postoperative pain is promis-
ing [18]. Therefore, acupuncture has a potential role in
the management of postoperative pain.
Although previous studies have suggested that
acupuncture and AA may be useful in relieving postop-
erative pain, the results are not compelling due to high
risk of bias associated with improper randomization, in-
adequate control, and lack of blinding and allocation
concealment. High-quality evidence is needed to confirm
the previous findings and support the use of acupunc-
ture for postoperative pain in the routine clinical setting.
We, therefore, propose a randomized, double-blind,
controlled trial using a rigorous methodology, adequate
allocation concealment, and validated outcome measures
to examine the efficacy of acupuncture as an adjunct
treatment in relieving postoperative pain after abdominal
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surgery for gynecological diseases. To maximize the
efficacy of acupuncture treatment, a combined approach
of EA and AA, which is commonly used in clinical prac-
tice, will be used.
We hypothesized that acupuncture, as an adjunct
treatment, is effective and safe to reduce postoperative
pain during the first 5 days following abdominal surgery
for gynecological diseases as compared to a sham con-
trol. The overall objective of this study is to examine the
safety and efficacy of a combined acupuncture treatment
of electroacupuncture (EA) and intradermal auricular
acupuncture (AA) as an adjunct treatment in reducing
postoperative pain in patients after abdominal surgery
for gynecological diseases, compared with sham EA in
combination with sham AA. Specifically, to test the
hypothesis, the objectives of the study are:
1. To determine the efficacy of acupuncture as an
adjunct treatment in reducing postoperative pain as
measured by the pain Numerical Rating Scale (NRS,
the primary outcome) and pain medication
consumption during the first 5 days after operation
to be calculated as the area under the curve (AUC)
to compare the between-group difference
2. To determine whether the acupuncture treatment
can shorten the time to recovery as measured by
time to recovery variables including time to recovery
of postoperative bowel functions and food intake;
time to ambulation and time to discharge
3. To evaluate the safety of acupuncture treatment in
postoperative pain in a hospital ward by comparing
the number of subjects with adverse events, number
of patients withdrawn and reasons of withdrawal in
treatment group with the sham control group
4. To assess whether acupuncture is cost-effective in
improving the postoperative quality of life of patients
using the Quality of Recovery-9 (QoR-9), Short
Form-6 dimension (SF-6D), and EQ-5D-5 L when
compared with sham acupuncture
Methods
Study design
The proposed study will be a randomized, parallel-
group, sham-controlled, subject- and assessor-blind trial
(number of sample, n =72). The trial will be commenced
after ethical approval has been obtained from the
Institutional Review Board. All study-related procedures
will be performed only after subjects have given their
written informed consent. The clinical trial is designed
and reported following the Consolidated Standards of
Reporting Trials (CONSORT) guidelines, the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) Checklist (Additional file 1), and
Standards for Reporting Interventions in Controlled
Trials of Acupuncture (STRICTA) recommendations.
Participants
Sample size estimation
Results from an earlier study of EA as an adjunct treat-
ment in postoperative pain were used for sample size
consideration [10], and the expected mean difference
and standard deviations of AUC in 5 days for the treat-
ment group and control group were obtained by simula-
tion using R [21].
The mean difference of AUC between treatment group
and sham group in the previous study [10] is 3.4 with
standard deviations of 2.9 for the treatment group and
3.6 for the sham group (effect size = 1.04). A lower limit
of the 70% confidence interval of the effect size which is
0.75 is applied [22]. A sample size of 30 per group can
provide 80% power to reject the null hypothesis with a
significance level of 0.05 using a two-sided, two-sample,
unequal-variance t test. With an expected dropout rate
of 15%, the final sample size is 72 (36 per group). AUC
is used to calculate the primary outcome measure be-
cause it provides information regarding the pain relief
across the whole period, which is more meaningful than
comparing the pain score at a particular time point.
AUC also has an advantage in that it avoids multiple
comparisons and thus will not inflate type I error. This
statistical analysis approach has been widely used and
reported by previous studies, including those published
in leading pain journals [23, 24].
Subject recruitment
This randomized, sham-controlled, double-blind (sub-
ject- and assessor-blind) trial will be conducted in the
Department of Obstetrics and Gynecology, at Queen
Mary Hospital. Potentially eligible subjects who have
scheduled for abdominal surgery for gynecological
diseases will be invited to participate. Patients will be
referred from a surgeon or gynecologist, and then a
research assistant will approach the subjects at the pre-
admission clinic or in the general ward pre operation.
Patients will be screened and consented for the study.
Following the consent, eligible participants will be block
randomized into two groups: (I) acupuncture (n = 36)
and (II) sham acupuncture (n = 36). All participants will
undergo a standard operative procedure and receive
postoperative analgesics according to usual practice.
Treatment will be given within 2 h prior to the surgery,
immediately after arrival on the ward, and daily follow-
ing surgery for 5 days. Assessments will be conducted
upon recovery, hourly at 6 h after surgery, then 4-hourly
until day 2 and then 6-hourly until discharge. (See Fig. 1
for the study flowchart, and Fig. 2 for the assessment
schedule).
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Inclusion criteria
1. American Society of Anesthesiologists (ASA)
physical status I to III
2. Eligible for laparotomy with midline incision for
gynecological neoplasm including ovarian mass,
uterine mass, and cervical lesions
3. Age 18 years or above
4. Ability to understand the nature of the study and
willing to give informed consent
5. Capable of providing responses during outcome
measurement
Exclusion criteria
1. Having chronic pain and using any medication in
addition to the anesthetic and analgesia prescribed
prior to surgery that would be expected to affect the
dosage of postoperative analgesia
2. History of or current alcohol or drug abuse
3. Impaired renal function, defined as preoperative
serum creatinine level over 120 μmol/L
4. Impaired hepatic function, defined as preoperative
serum albumin level below 30 g/L
5. Impaired or retarded mental state and not able to
sign the consent
6. Not self-ambulatory before operation
7. Difficulties in using patient-controlled analgesia
8. Body Mass Index > 35 kg/m2
9. Infection observed at the acupoint sites
10.History of acupuncture experience in the previous
12 months
11.History or clinical evidence of valvular heart defects,
heart failure, atrial fibrillation, or bleeding disorders
or are fitted with a cardiac pacemaker or taking
anticoagulant drugs
Randomization
Block randomization with a random block size ranging
from 4 to 8 will be used in this study. Participants are
randomly assigned to one of the two groups in 1:1 ratio
after completion of baseline assessment, according to a
randomized block list generated by an independent
research assistant using R and the code will be kept in
opaque sequentially numbered envelopes.
Allocation concealment
The treatment allocation codes will be enclosed by an
independent research assistant in sequentially numbered
opaque envelopes and will not be revealed until the par-
ticipants have completed all baseline assessments and
immediately before the first acupuncture treatment. To
minimize breaks in coding, multiple allocation codes will
be assigned to both groups. The principal investigator
(PI) who designed the trial, the co-investigators (Co-Is)
who perform the on-site screening, and research
personnel who perform the outcome assessments will be
blinded to the treatment assignment.
Blinding
Participants will be told that they will be randomly
assigned to either acupuncture treatment or acupuncture-
like sham treatment. The treatment procedure of
acupuncture treatment and sham acupuncture treatment
will be identical except that no skin penetration is in-
volved in sham acupuncture (the details will be described
in the “Study design – Sham acupuncture group” section).
Therefore, participants will be unaware of the treatment
that they received.
The principal investigator, other co-investigators, the
nurse, the research assistant responsible for data
collection and data entry and the statistician responsible
for data analysis will be blinded to the participants’
group allocation.
Only the acupuncturist will know the participants’
group allocation. However, the acupuncturist will not
Screening
Randomization 
(1:1)
EA+AA
EA+AA
EA
(once a day 
for 5 days)
+
AA
(retain & 
replace 
every 3 days 
for 5 days) 
Sham EA
(once a day 
for 5 days)
+ 
Sham AA
(retain & 
replace 
every 3 days 
for 5 days) 
Daily 
follow-up 
upon 
discharge/ 
up to day 5
Exclude
ineligible
subject
Operation
Within 2 
hours before 
operation
Main 
Assessments:
Primary outcome:
− Pain severity 
NRS 
Secondary 
outcomes:
− Cumulative 
morphine 
consumption
− Use of rescues 
analgesic
− Postoperative 
syndromes
− Quality of 
recovery
− SF – 6D
− EQ-5D-5L
Operation
Sham EA
+Sham AA
Sham EA+ 
Sham AA
Daily 
follow-up 
upon 
discharge/ 
up to day 5
Immediately 
after arrival 
to the ward
Hospital stay 
/ Telephone 
follow up
Fig. 1 Study flowchart. Abbreviations: EA electroacupuncture, AA
auricular acupuncture
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know any other information about the patients such as
the degree of the surgery, the amount of anesthetic used
during the surgery, and analgesics consumed post
surgery. To avoid accidental disclosure of group alloca-
tion by the acupuncturist, their interactions with the
participants will be kept to a minimum.
Quality assurance of acupuncture treatment
To ensure the quality of acupuncture treatment, pre-job
training and examination will be provided by the princi-
pal investigator (Prof. L Lao) to the acupuncturists. The
first treatment for the first five patients will be assessed
by an expert in acupuncture (appointed by the principal
investigator) who will confirm the location of the
acupoints and the depth of needling as accurate with a
checklist.
Treatment protocol
The acupuncture treatment will be conducted within 2 h
before surgery, after surgery at the ward and every 24 h
after the surgery for 5 days (seven treatment sessions in
total). A registered acupuncturist preferably with a
Master’s degree in acupuncture and at least 3 years’
acupuncture experience will be responsible for delivering
the acupuncture treatment.
Acupuncture treatment group
Preoperative acupuncture treatment (first acupuncture
session) and acupoint justification
Bowel preparation begins 1 day before the operation.
Participants will fast from midnight before the operation.
Within 2 h before the operation, participants will receive
the first acupuncture treatment, which consists of
Assessment S B O Postoperative Treatment period
Assessment
time point
Upon 
recovery,
Hourly at first 
6 hours after 
surgery
4-hourly, 
during the first 
2 days after 
surgery
6-hourly,
until day 3
Once daily 
until 
discharge
Basic Information
Informed consent
Review inclusion/
exclusion criteria
Demographics
Time of admission
Medical History
Height & Weight
Vital signs
Operation-related
Intraoperative vital signs 
Estimated intraoperative blood loss
Volume of intraoperative fluid/blood infusion
Duration of anaesthetic /analgesic procedures 
before surgical procedures
Duration of surgical procedures
Primary outcome
NRS pain scores at rest 
Secondary outcomes
NRS pain scores while coughing 
Cumulative morphine consumption
Dose and frequency of rescues analgesic (IM 
morphine) use
Tries and goods of PCA use
Time to recovery of bowel functions 
Time to recovery of food intake 
Time to ambulation 
Time to discharge
QoR-9
SF – 6D
EQ-5D-5L
Others
Adverse event monitoring (side effects and 
complications)
Patient’s satisfaction upon discharge
Success of blinding
Abbreviations: S Screening, B Baseline, O Operation, NRS Numerical rating scale, IM intramuscularly administered, PCA
patient-controlled analgesia, QoR-9 Quality of Recovery - 9, SF-6D Short Form-6 Dimension, EQ-5D-5L EuroQol -5 
Dimension -5 Level
* Conduct once a day
Fig. 2 SPIRIT - Figure: Study assessment schedule
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auricular acupuncture (AA) using filiform needles and
electroacupuncture (EA).
The acupuncture procedure will be performed follow-
ing the Hospital Authority (HA) Guideline on Safety in
Acupuncture for Chinese Medicine Practitioners [25].
AA will be performed in the supine position. Following
skin preparation with 75% alcohol swabs, sterilized, dis-
posable, filiform needles, each 15 mm long and 0.30 mm
in diameter, will be inserted through a needle-guiding
tube at the bilateral auricular acupoints Shenmen and a
reflex point of the pain site corresponding to the abdom-
inal region (four points in total). The needle-guiding
tube will be removed. A piece of adhesive tape will then
be immediately applied to the surface of the auricle. The
reflex point will be detected with an acupoint detector,
which works by detecting the low electrical resistance of
the auricular acupoints. The auricular acupoint selection
is based on previous studies [26, 27] and the traditional
auriculotherapy theory of using corresponding anatom-
ical body areas on the ears [28]. After that, a screening
curtain will be placed on a rack above the participant’s
chest to prevent the patient from watching the treatment
procedure. Acupuncture points (see Table 1): bilateral
LI4 (Hegu), ST36 (Zusanli), SP8 (Diji), SP10 (Xuehai),
and LR3 (Taichong) will be used in all sessions. In
addition, bilateral LR14 (Qimen), ST25 (Tianshu), EX-
CA1 (Zigong), and unilateral CV4 (Guanyuan) and
CV12 (Zhongwan) will also be used in the first session.
All acupoints will be located with reference to the most
recent acupuncture textbook of the International Stand-
ard Library of Chinese Medicine written by Zhang,
Zhao, and Lao [29]. A 75% alcohol swab will be used to
sterilize the points and skin around. Sterilized, dispos-
able filiform needle, each 25–30 mm long and 0.30 mm
in diameter, will be inserted at each point through a
needle-guiding tube with reference to the suggested
technique written in the textbook [29]. The needle-
guiding tube will be removed after the insertion of
needles. The needles will be manipulated to initiate a
sensation of “De qi.” An electric stimulator (AWQ-
104 L) will then be connected to eight pairs of needles:
LI4-ST36, SP8-LR3, bilateral LR14, bilateral ST25, CV4-
CV12, and bilateral EX-CA1. A low-frequency, 4-Hz
continuous wave will be selected. Treatment will be
carried on for 30 min. After the removal of needles,
clean cotton wool will be used to prevent bleeding by
compressing the points. The selection of acupoints is
based on the principle of traditional acupuncture
practice with a history of thousands of years [28, 29],
previous clinical trials [3–5, 12, 13, 30, 31], and experts’
opinions (Prof. L Lao). A total number of 18 acupoints
will be used in the first treatment and 14 acupoints will
be used in the subsequent treatments. The acupoint
selection and rationale are summarized in Table 1.
Postoperative acupuncture treatment (second to seventh
acupuncture sessions) and acupoint justification
After the operation, the patient will be transferred to the
ward after about 1 h. The subject will receive the second
acupuncture treatment on the arrival to the ward. After-
wards, the subject will receive an acupuncture treatment
every 24 h after the operation in the following 5 days
(third to seventh acupuncture sessions). From the second
acupuncture session onwards, a combined treatment
approach of EA and AA using AA needles will be used.
The treatment procedure of EA, including needling
procedure and electric-stimulation parameters, will be
the same as the first acupuncture treatment described
above, except that only four acupoints will be chosen
from the additional acupoints list: GB26, GB34, GB41,
HT3, HT7, KI4, KI6, LI11, LR5, LR14, LU7, PC6, SP6,
SP14, SP15, SP16, SP21, ST23, ST25, ST27, ST34, CV4,
CV12, and EX-CA1 with PC6 as the first choice. After
completion of EA, AA will be performed as the first
acupuncture treatment mentioned previously, but AA
needles will be used. AA needles inserted will be
retained and replaced every 3 days until discharge (in
case of discharging before day 5) or day 5.
Sham acupuncture group
To control for the non-specific effects of acupuncture, a
non-invasive sham acupuncture method will be per-
formed 1–2 cun away from the true acupoints, where no
meridians cross, [32, 33] in the control group.
Procedure
To ensure standardization of the needling technique and
how we convey to the subjects about “sham acupunc-
ture,” all acupuncture will be performed by the same
registered Chinese medicine practitioner. A backup
practitioner will also be trained in case the primary
practitioner is unavailable.
The acupuncture treatment procedure, including the
acupoints selection principle, sterilization procedure,
and treatment schedule (treatment time point, duration,
and total number of treatments) will be the same as the
treatment group except that non-invasive, retractable.
sham needles, an inactivated electric stimulator, a non-
invasive, sham-acupuncture procedure and dummy aur-
icular intradermal needles will be used on points 1–2
cun away from the true acupoints where no meridians
cross [32, 33]. Non-invasive, retractable, sham needles
designed by Streitberger will be used [34] for sham EA.
The sham needles are blunt needles that will not pene-
trate the skin during needle insertion. The handles of
these sham needles will slide over the needle when it is
compressed, giving the appearance of a needle penetrat-
ing the skin. The needles are held by surgical tape to
imitate the acupuncture procedure. The needles will be
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Table 1 Justification of acupoint in electroacupuncture for postoperative pain control based on Traditional Chinese Medicine (TCM)
Location TCM indication Suggested technique
Core acupoints (used in all treatment sessions)
LI4 (Hegu) Dorsum of hand, at the level of the midpoint
of the second metacarpal bone, between first
and second metacarpal bones
Helps in abdominal pain. Needle perpendicularly
0.5–1.0 cun
ST36 (Zusanli) Antero-lateral leg, 1 middle-finger breadth
next to the anterior crest of tibia, 3 cun under
the depression lateral to the patellar ligament
Stomach’s lower He point, helps in regulating Qi
and blood circulation.
Needle perpendicularly
0.5–1.5 cun
SP8 (Diji) Medial leg, posterior to the tibia, 3 cun under
the depression inferior and posterior to the
tibia medial condyle
Xi (Cleft) point of the Spleen meridian, helps in
abdominal pain
Needle perpendicularly
1.0–1.5 cun
SP10 (Xuehai) Antero-medial thigh, 2 cun above the medial
cranial pole of the patella.
Helps in tonifying and circulating blood Needle perpendicularly
1.0–2.0 cun
LR3 (Taichong) Dorsum of foot, within the depression
between first and second metatarsal bones.
Helps in regulating liver Qi and blood Needle obliquely upward
0.5–1.0 cun
Additional acupoints: Before surgery (first treatment session): LR14, ST25, EX-CA1, CV4, and CV12 will be used. After surgery (second to seventh treatment
sessions): 4 acupoints selected from below will be used, PC6 is the first choice
GB26 (Daimai) Lateral abdomen, at the level of the umbilicus,
below the free end of the 11th rib
Crossing point of the Gallbladder and the Dai
meridians
Needle obliquely
0.5–1.0 cun
GB34
(Yanglingquan)
Lateral leg, at the depression inferior and
anterior to the head of the fibula
He (Sea) point of the Gallbladder meridian and
Influential Point for the tendons
Needle obliquely upward
0.5–0.8 cun
GB41 (Zulinqi) Lateral-dorsal aspect of the foot, lateral side
of the little toe’s extensor muscle tendon
Shu (Stream) point of the Gallbladder meridian
and the meridian’s Confluence Point with the
Dai meridians
Needle perpendicularly
0.5–0.8 cun
HT3 (Shaohai) Elbow, at the middle of the medial end of
the transverse antecubital crease and the
medial epicondyle of the humerus
He (Sea) point of the Heart meridian, helps in
regulating heart
Needle perpendicularly
0.5–1.0 cun
HT7
(Shenmen)
Palmar aspect of the wrist, ulnar end of the
transverse crease
Shu (Stream) and Yuan (Source) points of the
Heart meridian, helps in calming the Shen (spirit)
Needle perpendicularly
0.3–0.5 cun
KI4 (Dazhong) Medial foot, at the back of and below the
medial malleolus, in depression in front of
the Achilles tendon
Helps in gynecological disorders Needle perpendicularly
0.5–1.0 cun
KI6 (Zhaohai) Medial foot, at the depression below the
medial malleolus
Helps in gynecological disorders Needle perpendicularly
0.5–0.8 cun
LI11 (Quchi) Elbow, at the middle of Chize and the lateral
epicondyle of the humerus
Helps in abdominal pain Needle perpendicularly
1.0–2.5 cun
LR5 (Ligou) Medial leg, 5 cun on top of the medial
malleolus.
Luo (Connecting) point of the Liver meridian,
helps in gynecological disorders
Needle transversely
0.5–0.8 cun
LR14 (Qimen) Thorax, on the mammillary line, in the six
intercostal space under the mammilla
Front Collecting Point (Mu point) of the Liver
meridian, helps in regulating liver Qi and blood
Needle transversely
0.5–1.0 cun
LU7 (Lieque) Antero-lateral forearm, in front of the styloid
process of the radius, 1.5 cun away from the
wrist crease
Confluence Point of the Ren meridian and the
Lung meridian
Needle obliquely upward
0.2–0.3 cun
PC6 (Neiguan) Palmar aspect of the forearm, between the
tendons, 2 cun away from the transverse
crease of the wrist
Luo (Connecting) point of the Pericardium
meridian, helps in gastric pain and calming
the Shen
Needle perpendicularly
0.5–1.5 cun
SP6
(Sanyinjiao)
Behind the medial tibia, 3 cun above the tip of the
medial malleolus
Helps in gynecological disorders Needle perpendicularly
0.5–1.0 cun
SP14 (Fujie) Abdomen, 4 cun away from the anterior midline, 1.3
cun below Daheng
Helps in peri-umbilical pain Needle perpendicularly
1.0–1.5 cun
SP15 (Daheng) Abdomen, 4 cun away from the umbilicus Helps in abdominal pain Needle perpendicularly
1.0–1.5 cun
SP16 (Fuai) Abdomen, 4 cun away from the anterior
midline, 3 cun above Daheng
Helps in abdominal pain Needle perpendicularly
1.0–1.5 cun
SP21 (Dabao) Lateral chest, in 6th intercostal space, on mid-
axillary line
Collateral meridian of Spleen, helps in total
body pain
Needle obliquely
backward 0.5–0.8 cun
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connected to an electric stimulator with zero frequency
and amplitude. For the sham AA in the first session, a
validated sham-acupuncture procedure [35] will be
adopted with small modification. A plastic needle-
guiding tube will be taped to the points on the auricle to
stimulate some discernible sensation. A needle with a
piece of adhesive tape will then be immediately applied
to the surface of the auricular acupoint [35]. For the
sham AA from the second session onwards, dummy
auricular intradermal needles with only circular handles
will be used. The dummy auricular intradermal needles
will be covered by adhesive tape.
Anesthesia, intraoperative care, and postoperative
management
Anesthesia
No participant will receive sedative premedication. On
arrival in the operating theatre, a 16-gauge intravenous
cannula will be inserted under local analgesia. Propofol
2 mg/kg, fentanyl 1.5 μg/kg, and atracurium 0.5 mg/kg
will be used for general anesthesia induction. A bolus
dose of 0.1 mg/kg morphine sulphate will be given
intravenously prior to incision. Pulse, pulse oximetry,
and non-invasive blood pressure measurement will be
checked every 5 min throughout the operation.
Intraoperative care
Anesthesia will be maintained with a mixture of
sevoflurane, air, and oxygen. The sevoflurane concentra-
tion will be titrated to optimal heart rate and blood
pressure by the anesthesiologist (Dr. CW Cheung and
his team members). At hours 3 and 4, morphine
sulphate 0.1 mg/kg may be given in divided dose titrated
to the patient’s response.
A thermal blanket and infusion fluid warmer will be
used to maintain core body temperature at 35.5 to 37.5 °
C. A urinary catheter will be inserted to monitor urine
output. An intermittent pneumatic compression device
will be applied to the lower limbs for deep vein throm-
bosis prophylaxis.
At the discretion of the anesthesiologist (Dr. CW
Cheung and his team members), hypotension will be
treated with intravenously administered ephedrine or
phenylephrine. Hypertension or tachycardia will be
treated with isoflurane up to 2% end-tidal concentration
(approximately 1.5 MAC). If persistent, beta-blockers,
such as labetalol, or arterial vasodilators, such as hydral-
azine, may be given. Sevoflurane will be switched off
after the closure of the inner layer of the wounds. All
participants will have local analgesia infiltrated to their
wounds at the end of operation. Reversal will be
achieved by intravenously administered neostigmine
50 μg/kg and atropine 20 μg/kg after the operation. The
patient will then be transferred to the recovery room for
monitoring then to the ward after about 1 h.
Postoperative management
All participants will be prescribed paracetamol 1 g every
6 h for 3 days and Celebrex 200 mg twice daily for
3 days. On arrival in the recovery room, boluses of 2 mg
of intravenously administered morphine will be given
every 5 min until the patient’s NRS pain score is less
than 4. The patient will be offered patient-controlled
analgesia (PCA). The PCA pump will be configured to
give 1 mg of morphine at a time and the lockout
duration will be set to 5 min. No basal infusion will be
given and the maximum dose limit will be 0.1 mg/kg/h.
From postoperative day 0, rescue analgesic in the form
of intramuscularly administered morphine 0.1 mg/kg
Table 1 Justification of acupoint in electroacupuncture for postoperative pain control based on Traditional Chinese Medicine (TCM)
(Continued)
Location TCM indication Suggested technique
ST23 (Taiyi) Abdomen, 2 cun above Tianshu Helps in reducing irritability Needle perpendicularly
1.0–1.5 cun
ST25 (Tianshu) Abdomen, 2 cun away from the navel Front Collecting Point (Mu point) of the Large
Intestine meridian, helps in circulating Qi
Needle perpendicularly
1.0–1.5 cun
ST27 (Daju) Abdomen, 2 cun below Tianshu Helps in lower abdominal distention and pain Needle perpendicularly
1.0–1.5 cun
ST34
(Liangqiu)
Anterior thigh, 2 cun above the superior
lateral corner of the patella
Xi (Cleft) point of the Stomach meridian, helps
in acute stomachache
Needle perpendicularly
1.0–1.5 cun
CV4
(Guanyuan)
Abdomen, 3 cun under the navel Front Collecting Point (Mu point) of the Large
Intestine meridian, helps in invigorates original
Qi (Yuan Qi)
Needle perpendicularly
0.5–1.0 cun
CV12
(Zhongwan)
Abdomen, 4 cun above the navel Front Collecting Point (Mu point) of the Stomach
meridian, Master Point of the Fu organs, helps
in regulating Qi
Needle perpendicularly
0.5–1.0 cun
EX-CA1
(Zigong)
Abdomen, at the level of 4 cun under the
navel and 3 cun away from the midline
Helps in gynecological disorders Needle perpendicularly
0.8–1.2 cun
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will be prescribed every 4 h if necessary. During the
administration of PCA morphine, the patient will be
seen by an anesthesiologist, who is blinded to treatment
allocation (Dr. CW Cheung and his team members),
every day to assess the adequacy of analgesia.
PCA morphine will be administered for at least 2 days.
On postoperative day 2, if the participant’s NRS pain
score during cough is less than 4 on a clinically low
morphine consumption, PCA will be stopped; if the
NRS pain score is 4 or above, or her PCA consumption
is still high, it will be continued. Assessment will be
repeated daily. If a patient’s NRS pain score during a
cough remains at 4 or above on day 5, she will be
evaluated for complications and managed at the discre-
tion of the anesthesiologist (Dr. CW Cheung and his
team members).
Measures
Outcome assessment
Subjects will be closely monitored during and after the
operation. The primary outcome will be participants’
postoperative pain scores at rest measured by Numerical
Rating Scale (NRS) for the first 5 days after operation.
The secondary outcomes include postoperative NRS
pain scores while coughing; dose and frequency of
rescue analgesic use during hospital stay; time to recov-
ery variables; QoR-9, SF-6D, and EQ-5D-5 L. If at any
time point after the operation, a participant is unable to
be managed according to the protocol for any reason,
such as the development of complications, no further
data will be collected. Telephone follow-up will be
offered for participants discharged before day 5 (Fig. 2).
Primary outcome measure
Pain intensity by Numerical Rating Scale (NRS) at rest
The NRS for pain is a 0–10-point scale with 0 indicating
no pain and 10 indicating worst possible pain. NRS pain
scores will be measured at rest upon recovery, hourly at
6 h after surgery, then 4-hourly until day 2, 6-hourly until
day 3 and then once daily until discharge. The NRS is a
commonly used scale for clinical pain research. NRS is
chosen because it is easier for patients to grade their pain
intensity with numbers and it has been shown to correlate
well with the Visual Analog Scale and Brief Pain Inventory
as well as other pain measurements [36–39].
Secondary outcome measures
Pain intensity by Numerical Rating Scale (NRS) while
coughing
The NRS for pain while coughing will be measured
hourly at 6 h after surgery, then 4-hourly until day 2,
then 6-hourly until day 3 and then once daily until
discharge.
Cumulative morphine consumption
Postoperative PCA morphine consumption will be
recorded in each participant’s medication log during the
hospital stay.
Dose and frequency of rescue analgesic (intramuscularly
administered morphine) use
The time to first postoperative use, dose, and frequency
of rescue analgesic will be monitored and recorded in
each subject’s medication log during the hospital stay.
Time to recovery variables
The time to recovery of postoperative bowel function
and food intake; time to ambulation and time to
discharge will be assessed and recorded by physicians
during the hospital stay.
Quality of Recovery-9 (QoR-9)
The QoR-9 is a nine-item questionnaire, which has been
extensively utilized and validated to assess the patients’
quality of recovery after anesthesia [40].
Short Form-6 dimension (SF-6D) and EuroQol -5 Dimension-5
Level (EQ-5D-5 L)
Quality of life will be assessed by using a Chinese-
translated and validated Medical Outcomes SF-6D and
EQ-5D-5 L. The SF-6D and EQ-5D-5 L are a preference-
based measure of health (PBMH) for economic evalu-
ation. The SF-6D is composed of six multi-level dimen-
sions, namely, physical functioning, role participation,
social functioning, bodily pain, mental health, and vitality,
whereas the EQ-5D-5 L has five dimensions for health sta-
tus description: mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression. The SF-6D and EQ-
5D-5 L value set [41, 42] for the Chinese population will
be used to derive utility scores.
Side effects associated with opioid use
The occurrence of opioid side effects, including pruritus,
sedation, dizziness, nausea, and vomiting and urinary
retention, will be accessed.
Safety assessment
Reasons for withdrawal
When a participant withdraws before completing the
study, the reasons for withdrawal will be recorded.
Adverse events
Adverse events occurring during the study period will be
recorded. Vital signs, including heart rate, respiratory
rate and blood pressure, will be assessed. The researcher
will interview participants using an adverse event record
form daily during the hospital stay.
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Credibility assessment
The Credibility of Treatment Rating Scale will be used
to assess the credibility of the acupuncture treatments.
This four-item scale is specially designed to assess the
credibility of acupuncture [43]. It assesses participants’
“confidence in the treatment to alleviate their com-
plaint,” “confidence in recommending the treatment to
their friends who have similar complaints,” “perceived
logic of the treatment,” and “likelihood that the treat-
ment would alleviate their other complaints.”
Blinding success assessment
After the final treatment, the success of blinding will be
tested by asking participants in the acupuncture treat-
ment group and the sham acupuncture group the fol-
lowing question: “When you volunteered for the trial,
you were informed that you had an equal chance of
receiving traditional acupuncture or acupuncture-like
simulation treatment. Which acupuncture do you think
you received?” Three response options will be provided
for patients to choose from: acupuncture treatment,
acupuncture-like simulation treatment, and uncertain.
Those who choose either acupuncture treatment or
acupuncture-like sham will be asked to provide a reason
why they have made that assumption [9].
Monitoring
Data and safety monitoring plan
A Data and Safety Monitoring Board (DSMB) will be
formed according to the National Institutes of Health
(NIH) to monitor the study progress and review safety
and quality of data [44]. The committee consists of three
members, including a senior acupuncturist, a pain
specialist, and a biostatistician. The DSMB is independ-
ent of the proposed study and all the committee
members will have to declare any conflict of interest in
the study. Regular board meetings will be held to ensure
that data are collected scientifically and ethically and
subjects are not exposed to unnecessary risks [44].
Data processing and analysis
Data management
Data will be collected by blinded assessors. All data will
be double-entered and checked for consistency prior to
analyses. If an immediate entry is not possible, data col-
lected in paper form will be scanned and coded with
subjects’ codes. All the data collected will be locked, and
the Personal Data (Privacy) Ordinance (CAP 486) in
Hong Kong will be complied with.
Statistical analyses
Statistical analyses will be performed using Statistical
Product and Service Solutions (SPSS) 22 (or above) for
Windows (SPSS, Chicago, IL, USA) or SAS. The
intention-to-treat (ITT) approach will be used. Descrip-
tive analyses will be done on baseline demographics.
To analyze the primary outcome, AUC of the NRS
pain scores at rest will be calculated by plotting on the
timescale using the trapezoidal method, and the compar-
isons between groups will be made using the Student’s t
test. Missing NRS scores will be replaced by linear
interpolation in cases if the missing scores fall between
two valid scores, or by multiple imputations if the miss-
ing score is the last pain score taken on day 5.
The NRS pain scores while coughing will be analyzed
in the same way as the pain scores at rest. For other
secondary outcomes, cumulative morphine assumption
between the two groups will be compared with Student’s
t test or the Wilcoxon rank-sum test; time-to-event data
will be analyzed by the method of survival analysis.
Median time to event will be calculated using the
Kaplan-Meier product limit estimator, and log-rank test
will be used to determine the statistical significance of
the treatment difference in the survival curves for those
time-to-event variables. Analyses of secondary outcomes
are not part of the power calculations of the study, and
should, therefore, be considered exploratory. All tests
are two-tailed, and a p value of less than 0.05 is consid-
ered statistically significant. The effect size will be esti-
mated by Cohen’s d which is the mean difference
between groups per pooled standard deviation. The
mean difference and its 95% confidence interval will also
be calculated using SPSS.
Safety analyses
The population for safety analyses will include all partic-
ipants enrolled in the trial. Participants will be informed
the potential adverse events related to acupuncture
procedure such as bruises, hematomas, infection, pain,
chondritis, during the signing of inform consent.
Adverse events will be coded using the World Health
Organization (WHO) Adverse Reaction Terminology
Dictionary. The research assistant will follow-up the par-
ticipant’s adverse event until it has resolved, subsided,
stabilized, or the event is otherwise explained. Special
attention will be given to those participants who have
discontinued treatment due to adverse events or who
experience serious adverse events.
Health economic evaluation
The cost-effectiveness analysis will be performed using
incremental cost-effectiveness ratio of acupuncture vs
sham acupuncture, i.e., (cost of acupuncture minus cost
of sham acupuncture)/(effectiveness of acupuncture
minus effectiveness of sham acupuncture) as a health
economic outcome.
The perspective of health service provider will be
adopted when evaluating the costs of implementation of
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acupuncture as an adjunct treatment in the postopera-
tive pain management in public inpatient setting. Only
direct medical costs for two groups will be calculated.
The costs to be included are staff time costs and treat-
ment cost for patients. To estimate the staff time cost
for making referrals, the time spent on each participant
by each staff member will be recorded. The average
number of minutes spent will be multiplied by the
relevant salary rate per minute. The length of hospital
stay will be recorded to estimate the cost by the multi-
plication of the number of inpatient days with inpatient
hospital stay cost per day according to the most updated
Government Gazette.
The acupuncture treatment cost will be estimated for
each treatment in terms of acupuncturist’s time spent on
delivering the treatment, including traveling time, multi-
plied by salary rate per minute. The cost of analgesics,
acupuncture needles and other consumable will be
calculated. The capital cost included the electric stimula-
tor with 10% annual maintenance fee.
The effectiveness of acupuncture and sham acupunc-
ture groups will be measured by quality-adjusted life
expectancy using the AUC method which aggregates the
PBMH value, measured by either SF-6D or EQ-5D-5 L,
from baseline day to the study end day.
Discussion
The study protocol of the proposed trial will be
conducted at the Queen Merry Hospital which is under
the Hong Kong HA. Unlike many hospitals in the West
and in China, acupuncture has become a routine in-
patient service [45–47]. However, currently, acupuncture
is not available in the Hong Kong HA system. The
present study is designed to investigate whether it is
feasible, effective and safe to use acupuncture as an ad-
junctive therapy for patients who suffer from postopera-
tive pain and discomfort. If successful, the study would
provide useful information for integrating acupuncture
into perioperative care as part of the effort of integrating
Chinese and Western medicine in Hong Kong hospitals.
This study protocol faces several challenges and limita-
tions. Firstly, patients with different types of gynecological
neoplasia requiring laparotomy will be included, which
may create variability in the population. However, as
wound pain is the main target of treatment, the variation
of types of neoplasm would not be a great problem. To
address this issue, only patients with midline incision are
recruited, which would likely involve similar degrees of
wound pain being experienced by each patient. In
addition, randomization will be done rigorously so that
the types of neoplasm in the two groups can be balanced.
Secondly, although in many of the previous trials on
postoperative abdominal surgical pain, acupuncture was
performed before the induction of anesthesia in the
operating theater [3, 13, 31], it is infeasible to conduct
preoperative acupuncture in our operating theaters
which will lengthen the interval time between preopera-
tive acupuncture being performed and the actual oper-
ation. This is because the surgical team was concerned
about the underlying risks and potential liability. There-
fore, in this trial, preoperative treatment will be carried
out in the ward within 2 h before the operation.
Thirdly, the surgery time is uncertain and often varies
due to the nature of the various underlying diseases,
making it difficult to schedule an acupuncture treat-
ment. To solve this problem, preoperative acupuncture
will be arranged based on the estimated time of the op-
eration list and the first postoperative treatment will be
done upon arrival on the ward. The exact operation time
and acupuncture treatment time will be recorded for
further analysis.
Fourthly, it is not appropriate to regard sham acupunc-
ture as a mere placebo or control group, although non-
insertion sham acupuncture has been chosen in this study
to maximize the treatment between the two groups [48].
Treatment costs incurred in the sham acupuncture arm
involve sham acupuncture needles which will be assumed
to cost the same as the acupuncture needles. The treat-
ment efficacy of the sham acupuncture will not be as-
sumed to be the same as that for the control group. In
line with a previous randomized, sham-controlled trial
alongside cost-effectiveness analysis of acupressure [49],
the sham arm was one of the study arms for effectiveness
and cost-effectiveness evaluation. Therefore, sham acu-
puncture will be considered as one competing interven-
tion in the cost-effectiveness analysis.
Though there are many difficulties, the quality of the
trial will be closely monitored by the Data and Safety
Monitoring Board (DSMB) which is an independent
board composed of a biostatistician, a senior Chinese
medicine practitioner, and an anesthesiologist. It is
hoped that this study will provide high-quality evidence
on the efficacy and safety of acupuncture for alleviating
postoperative pain as well as useful information for
health economic analysis.
We hope that our findings will advance knowledge on
the effectiveness of acupuncture in routine integrative
medicine practice in Hong Kong hospital settings.
Trial status
The first patient was recruited on 12 October 2016.
Patient recruitment is being continued.
Additional file
Additional file 1: Completed SPIRIT 2013 Checklist: items addressed in
this clinical trial protocol and related documents. (PDF 173 kb)
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